In this parallel-group randomized clinical trial, mirtazapine delivered in routine clinical practice reduced methamphetamine use in adults with methamphetamine use disorder.
Searching for Solutions
In this study, higher cumulative doses of methadone during the first 48 hours of care were associated with substantial reductions in the incidence of PDD.
This study evaluated the potential association between prenatal acetaminophen exposure and risk of autism using Danish nationwide registers.
Collegiate Chapter Impact Grant recipients will share their grant-funded projects during the Collegiate Chapter Meeting on Sunday, 4/19! Join chapter representatives in the Cedar Ballroom from 4:45-5:15 PM Pacific Time. Presentations will not be livestreamed; however, they will be recorded and posted for those unable to attend live. Thank you to our donors for helping us continue this important grant program with your monetary gifts.
Thanks to generous AAPP Foundation donors and the AAPP Past Presidents' Destiny Fund, 33 PharmD students were awarded full, in-person student registration grants to AAPP 2026! Congratulations to each of the recipients and enjoy your time in Seattle!
AAPP joined numerous other Mental Health Liaison Group member organizations in expressing strong coalition support for the introduction and swift passage of legislation to remove the 190-day lifetime limit on inpatient psychiatric treatment for Medicare beneficiaries.
The xylazine toolkit, intended to highlight the evidence base available and strategies of clinical decision making, was recently updated by AAPP member Sarah Thomason to include sections on regulatory status, laboratory testing and wound care.
In this year’s report, OCP celebrates its 30th anniversary, showcasing the Office’s contributions to the evolution of clinical pharmacology into a foundational pillar of drug development and regulatory review by enhancing efficacy and safety evaluations through rigorous, collaborative, and state-of-the-art approaches.
US adults likely have heterogenous views on addiction, and more research is needed to further understand how US adults conceptualize addiction.
In this study, SROM for OUD was associated with slightly higher treatment discontinuation risk than methadone but similar mortality risk, suggesting either medication may be appropriate alongside measures to support retention.
Stimulant-induced psychosis occurs in both therapeutic and nontherapeutic contexts but at vastly different prevalence rates.
While both PWUF and clinicians identified precipitated withdrawal as a major concern when initiating buprenorphine, it was just one of many barriers.
This paper provides an overview of SED, including the role of functional impairment in identifying youth with SED and the important developmental considerations.
This report provides a guide to publicly accessible data sources to support research and improve data-driven decision-making for individuals dually eligible for Medicaid and Medicare.
State Medicaid expansions from 2017 to 2023 increased access to medication treatment for opioid use disorder at a time when fatal overdoses were continuing to climb, researchers wrote in JAMA Network Open. That means coverage expansions can significantly affect uptake of addiction medicine like buprenorphine. The findings could be important for state governments wrestling with reductions in federal Medicaid spending.
The CDC and White House Office of National Drug Control Policy (ONDCP) issued an advisory to notify the public about increasing reports detecting medetomidine in the illegal drug supply causing withdrawal syndrome. Medetomidine is used for sedation and analgesia in dogs but is not approved for human use. Medetomidine can cause sedation, bradycardia, and hypotension and stopping it after regular use may lead to severe withdrawal.
These papers call on state leaders to refocus on SMI and serious emotional disturbances (SED) treatment and recovery— and to renew their commitment to system changes in improving whole-person health.
The primary outcome was change in Fatigue Severity Scale (FSS) score.
Evidence suggests that patients who lose a primary care physician experience higher emergency department use.
These findings suggest that PAT is no more effective than TADs under equal-unblinding conditions for the treatment of depression and highlight the potential role of blinding integrity.
Further research is needed to better characterize kratom’s mechanisms of liver injury and to inform clinical decision-making and public health policy.
These findings provide evidence-based guidance for treatment duration, realistic expectation-setting, and individualized prognosis determination in cannabis use disorder recovery.
The primary study outcomes were ROI ratios and net profits after 3 years in operation.
Fewer than half of outpatient facilities for substance use disorder accept Medicare, according to a new HHS report. But low reimbursement rates and difficulty finding mental health workers factor into clinics' ability to care for older adults who need behavioral health care, the report found.
Nicotine vaping is likely to cause lung and oral cancers, a comprehensive review of more than 100 studies has concluded. According to the analysis, human and animal studies, as well as cell experiments looking at the effects of chemicals found in vape liquid, all point toward carcinogenicity. Those studies, published since 2017, record "increasing concern", the researchers report.